66 results
Page 2 of 4
8-K
EX-99.1
q3tdj9j79p5ns65f
10 Jan 22
Other Events
8:00am
8-K
EX-99.1
5eaugy
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
EX-99.1
ub534ao
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.2
6671vqjx60e5
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
h21 6zkcp3i0tlq3
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
izjy k9f3guun7oy7zl
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
qu9pmxv
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
71cla3g4
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-10.1
p0ewz8ib 20was90r
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
nqtbxpojbnuj p28ty4
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am
8-K
EX-99.1
o0s7z7g
5 Aug 20
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
8:22am
424B5
fcw o5aqbx
12 Jun 20
Prospectus supplement for primary offering
4:31pm